Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (338)	9/1/1998 8:49:00 AM
From: John Dwyer	Respond to of 4474

I was one of those buyers... didn't pick up too many shares as I already have a fairly large position but couldn't pass it up. ARIA seems like a steal to me at these levels... granted, they are not going to have an approvable drug anytime soon but I expect them to sign one, maybe two deals and start two clinical trials within the next six months. If they can come through, the news should stabilize the price and provide some financial support (cash is getting kinda low). It would also demonstrate continued progress within their platform. The stock price will follow eventually. I'm in ARIA for the long haul. For a rebound, I bought sizable chunks of DELL and LU calls... I don't expect the biotechs to rebound as quickly as the big high tech stocks. Let's just hope they rebound sometime! Good luck to everybody!! John